Translating Ideas into Therapies 2021- Co-hosted with the British Pharmacological Society

Sponsor: bit.bio

bit.bio

Where: 04
bit.bio combines the concepts of cellular reprogramming and biology to provide human cells for research, drug discovery and cell therapy, enabling a new generation of medicines

This is possible with our precision cellular reprogramming technology, opti-ox™ - a core component of our Cell Identity Coding Platform. opti-ox is a breakthrough gene engineering approach that enables unlimited batches of any human cell to be manufactured consistently at scale through direct reprogramming of stem cells.

Under our ioCells brand we already have a wide range of wild type and disease model cells available for research and drug discovery including nerve cells, immune cells and muscle cells. Our portfolio is expanding at pace and all our cells are powered by opti-ox so are consistent, easy to use and highly defined.

We are currently building a clinical pipeline of cell therapies. Our areas of development are liver, immune and metabolic.
Tel: 01223 787 297
Address: The Dorothy Hodgkin Building
Babraham Research Campus
Cambridge
Website: https://bit.bio/
Email: info@bit.bio

Staff Attending

Crawford
Ms Abbey Crawford
Commercial Marketing Manager
Bit Bio Limited
  View Profile  
Frolov
Dr Tonya Frolov
Product Manager
bit.bio
  View Profile  
Nicoll
Miss Roisin Nicoll
Sales Manager
Bit Bio
View Profile  
Patell-Socha
Dr Farah Patell-Socha
VP Research Products
bit.bio Ltd
View Profile  

Find out more...

To view the virtial stand - please login first

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure Our partners and distributors

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure bit.bio Secures Distribution Agreement with Abcam

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure bit.bio Secures Distribution Agreement with Abcam

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure bit.bio Secures Distribution Agreement with Abcam

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

LinkedIn URL

Twitter